Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113735778B reveals efficient silver oxide promoted route. Delivers high purity intermediates with scalable cost reduction for global supply chains.
Patent CN110183378A details a copper-catalyzed route for high-purity pharmaceutical intermediates. This method offers significant cost reduction and supply chain reliability for global buyers.
Novel metal-free route for trifluoromethyl pyrazoles. Room temperature reaction ensures cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for quinoline-4(1H)-one. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and streamlined supply chains.
Novel glucose-based route for trifluoromethyl triazoles offering cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturing.
Patent CN116640146B details a novel Pd-catalyzed route for trifluoromethyl chromone quinoline intermediates offering scalable production and cost efficiency for pharmaceutical supply chains.
Novel Pd-catalyzed tandem cyclization method offers mild conditions and high atom economy for complex heterocyclic pharmaceutical intermediates.
Novel metal-free synthesis for high-purity azaspiro compounds. Reduces cost and supply chain risk for pharmaceutical manufacturing.
Patent CN114195726B details a novel CuCl-catalyzed route for 1,2,4-triazolyl arylamines, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel metal-free synthesis method for trifluoromethyl selenium azaspiro compounds offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds with high enantioselectivity for pharmaceutical applications.
Novel synthesis route avoids expensive catalysts. High purity pharmaceutical intermediate. Cost-effective scale-up for global supply chains and procurement.
Patent CN113735778B reveals efficient Ag2O promoted synthesis. Delivers high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.
Patent CN107663149A details a novel selenium-catalyzed route for phenanthrenequinone. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.
Patent CN112126941B reveals a green electrochemical route for 10-hydroxyphenanthrene derivatives, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN113683595B reveals sulfur-promoted route for high-purity pharmaceutical intermediates. Offers cost reduction and scalable manufacturing solutions.
Patent CN107629049A offers efficient pyrido isoindole synthesis. Low cost catalysts, air conditions, high yield for pharma intermediates.